Pictet Asset Management (Switzerland)’s Arcus Biosciences RCUS Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$12.9M	Sell	634,045 -649,798	-51%	-$12.4M	0.02%	569
2023 Q1	$23.4M	Buy	1,283,843 +19,860	+2%	+$380K	0.03%	431
2022 Q4	$26.1M	Sell	1,263,983 -225,460	-15%	-$6.2M	0.04%	389
2022 Q3	$39M	Sell	1,489,443 -423,108	-22%	-$11.2M	0.06%	311
2022 Q2	$48.5M	Buy	1,912,551 +357,539	+23%	+$8.76M	0.07%	282
2022 Q1	$49.1M	Sell	1,555,012 -93,978	-6%	-$3.15M	0.06%	314
2021 Q4	$66.7M	Buy	1,648,990 +147,762	+10%	+$5.73M	0.07%	297
2021 Q3	$52.3M	Buy	+1,501,228	New	+$46.7M	0.06%	331

Other funds holding RCUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s RCUS Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Arcus Biosciences (RCUS) stake by 51% in Q2 2023, selling an estimated $12.4M and leaving 634,045 shares worth $12.9M. The position accounts for 0.02% of the portfolio, ranked #569.

Pictet Asset Management (Switzerland) first reported a position in RCUS in Q3 2021 and has held it in 8 quarters since. The position peaked at $66.7M in Q4 2021. 181 funds tracked by Wall St. Rank hold RCUS as of Q2 2023.

Pictet Asset Management (Switzerland) held 634,045 shares of Arcus Biosciences worth $12.9M as of Q2 2023.
Pictet Asset Management (Switzerland) sold 649,798 Arcus Biosciences shares in Q2 2023, an estimated $12.4M.
Arcus Biosciences made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #569 holding.
Pictet Asset Management (Switzerland) first reported a position in Arcus Biosciences in Q3 2021 and has held it in 8 quarters since.
Pictet Asset Management (Switzerland)'s Arcus Biosciences position peaked at $66.7M in Q4 2021.
181 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.